CEPHALEXIN CAPSULES

The Defense Logistics Agency awarded a delivery order under contract SPE2DX-25-D-9900 to DMS Pharmaceutical Group Inc. for the procurement of 13 bottles of Cephalexin Capsules, identified by NSN 6505017240531, with a total value of $738.27. The award was issued on July 14, 2026, with delivery required by July 29, 2026, to Fort Bragg, North Carolina, under FOB Destination terms, meaning the contractor assumes all transportation costs and risks until receipt at the destination. The product is intended for military medical use and must be shipped via traceable means, with all packaging and documentation clearly marked using the Transportation Control Number W50YF252590056 and identifying details from the order. DMS Pharmaceutical Group Inc. is certified as a small, women-owned business, and no other socioeconomic certifications apply. The order is a single-line-item purchase with no option quantities or price variance permitted, and payment will be processed by the Defense Finance and Accounting Service in Columbus, Ohio, using a standard government voucher system. The contracting officer, Lisa Quinn, and administrative contact Shairy M. Cartagena, both located in Philadelphia, Pennsylvania, oversee contract administration, though no Contracting Officer’s Representative is designated. No specific technical, packaging, preservation, or quality standards beyond federal procurement compliance are detailed in the document, and no MIL-STD references or FAR clauses are explicitly included. The underlying contract vehicle is a basic agreement, and this delivery order represents a straightforward fulfillment action governed by inspection and acceptance at the destination under government authority.